Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti–PD-1 Therapy
Xiaona Fan(Harbin Medical University), Zhiwei Li(Nanchang University), Zhigang Ma(Gansu Provincial Hospital), Changjie Lou(Harbin Medical University), Hengzhen Li(Harbin Medical University), Xiaobo Li(Shanxi Medical University), Chao Liu(Harbin Medical University), Wenjing Zhang(Shandong University), Guangyu Wang(Tongji University), Qingwei Li(Liaoning Normal University), Jiani Yang(Harbin Medical University), Xin Guan(Jiangsu Cancer Hospital), Jinshuang Liu(Harbin Medical University), Dan Wang(Breast Cancer Now), Yibing Bai(Chinese PLA General Hospital)
Cited by 65
Related Papers
Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018
|New England Journal of Medicine|2021|684
Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
|Journal for ImmunoTherapy of Cancer|2019|231
An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer
|Molecular Therapy — Nucleic Acids|2018|211
Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p
|Cancer Research|2019|207